Clinical Trials
20 trialsTotal Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Total Neoadjuvant Therapy in Rectal Cancer
National Cheng-Kung University Hospital
SHOOL
Rajiv Gandhi Cancer Institute & Research Center, India
CombinaiR3
Institut Curie
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
City of Hope Medical Center
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University
ARO 2024-13
University Hospital Tuebingen
NeoCaCRT
Shenzhen People's Hospital
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
Larissa University Hospital
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
The First Affiliated Hospital with Nanjing Medical University
Leukemia Stem Cell Detection in Acute Myeloid Leukemia
Wake Forest University Health Sciences
Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
Alexandria University
AML
University Hospital Carl Gustav Carus
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL
First Affiliated Hospital Xi'an Jiaotong University
ICONA
Institute of Oncology Ljubljana
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
ChineseAMS
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma
French Innovative Leukemia Organisation
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
Hospital Israelita Albert Einstein
Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer
Samsung Medical Center